Siemens Healthineers Showcases Role of Digitalization at AACC 2018
By LabMedica International staff writers Posted on 31 Jul 2018 |

Image: A screenshot of the Atellica Data Manager (Photo courtesy of Siemens Healthineers).
At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers (Erlangen, Germany) showcased an array of digital offerings that turn data into actionable information to address a variety of clinical and operational challenges facing laboratories.
Siemens Healthineers provided a preview of the soon-to-be-released Atellica Data Manager that delivers clinical details lab managers need to make informed decisions. Atellica Data Manager operationalizes data from patient samples and QC results to standardize testing, optimize QC performance, and maximize the potential of autoverification while reducing operator interventions, unwarranted variations and errors. Open and scalable, Atellica Data Manager is built on the powerful CentraLink solution currently in use by 1,500+ laboratories in more than 50 countries to help optimize clinical operations, increase testing volumes and improve turnaround times.
At AACC 2018, Siemens Healthineers displayed Atellica Inventory Manager, which provides automated, real-time control over reagents and consumables across multiple lab locations to reduce inventory costs, save time, and improve efficiencies. Pre-labeled radio frequency identification (RFID) tags simplify inventory check-in, checkout, and consumption tracking, and, when enabled, consumables can be ordered automatically through cloud-enabled software.
Also on display at the event was Atellica Process Manager, which in addition to offering laboratories centralized control and visibility, now provides advanced analytics and business intelligence capabilities, enabling labs to gain real-time insight into hidden inefficiencies in their workflow. Out-of-the box and interactive reports enable lab managers to assess key metrics such as turnaround times, testing volumes, problem samples, and automation utilization.
Additionally, the company displayed POCcelerator Data Management System which is designed to address daily point-of-care challenges such as quality control, compliance and operator certification, and offers point-of-care coordinators vendor-neutral, open connectivity to more than 170 devices, giving coordinators visibility into results, quality controls, operators, reagents, and device data. The information is presented in a clear and structured format. Proactive error logs and a traffic-light system indicate potential problems that can be acknowledged with a single click.
Siemens Healthineers demonstrated its investment in transforming healthcare through digital innovations with its Digital Ecosystem. The open and secured cloud environment combines data from lab and imaging devices, which can be leveraged by applications from Siemens Healthineers and other partner companies to provide solutions to the lab. The company also showcased its first lab partner XIFIN and demonstrated how its Revenue Cycle Management solution helps to optimize the laboratory’s financial performance, by identifying potential outreach and outpatient testing reimbursement gaps.
Complementing the company’s digital offerings, Siemens Healthineers featured its Laboratory As A Business (LAAB) Consulting Service designed to address clinical, operational and financial challenges of laboratories, and help position the lab as a decision maker and a powerful contributor to the objectives of value-based care in health systems. LAAB recommends or structures sustainable solutions that help achieve strategic business objectives by leveraging the capabilities of the lab and informatics offerings, expertise, and competencies from Siemens Healthineers.
Siemens Healthineers provided a preview of the soon-to-be-released Atellica Data Manager that delivers clinical details lab managers need to make informed decisions. Atellica Data Manager operationalizes data from patient samples and QC results to standardize testing, optimize QC performance, and maximize the potential of autoverification while reducing operator interventions, unwarranted variations and errors. Open and scalable, Atellica Data Manager is built on the powerful CentraLink solution currently in use by 1,500+ laboratories in more than 50 countries to help optimize clinical operations, increase testing volumes and improve turnaround times.
At AACC 2018, Siemens Healthineers displayed Atellica Inventory Manager, which provides automated, real-time control over reagents and consumables across multiple lab locations to reduce inventory costs, save time, and improve efficiencies. Pre-labeled radio frequency identification (RFID) tags simplify inventory check-in, checkout, and consumption tracking, and, when enabled, consumables can be ordered automatically through cloud-enabled software.
Also on display at the event was Atellica Process Manager, which in addition to offering laboratories centralized control and visibility, now provides advanced analytics and business intelligence capabilities, enabling labs to gain real-time insight into hidden inefficiencies in their workflow. Out-of-the box and interactive reports enable lab managers to assess key metrics such as turnaround times, testing volumes, problem samples, and automation utilization.
Additionally, the company displayed POCcelerator Data Management System which is designed to address daily point-of-care challenges such as quality control, compliance and operator certification, and offers point-of-care coordinators vendor-neutral, open connectivity to more than 170 devices, giving coordinators visibility into results, quality controls, operators, reagents, and device data. The information is presented in a clear and structured format. Proactive error logs and a traffic-light system indicate potential problems that can be acknowledged with a single click.
Siemens Healthineers demonstrated its investment in transforming healthcare through digital innovations with its Digital Ecosystem. The open and secured cloud environment combines data from lab and imaging devices, which can be leveraged by applications from Siemens Healthineers and other partner companies to provide solutions to the lab. The company also showcased its first lab partner XIFIN and demonstrated how its Revenue Cycle Management solution helps to optimize the laboratory’s financial performance, by identifying potential outreach and outpatient testing reimbursement gaps.
Complementing the company’s digital offerings, Siemens Healthineers featured its Laboratory As A Business (LAAB) Consulting Service designed to address clinical, operational and financial challenges of laboratories, and help position the lab as a decision maker and a powerful contributor to the objectives of value-based care in health systems. LAAB recommends or structures sustainable solutions that help achieve strategic business objectives by leveraging the capabilities of the lab and informatics offerings, expertise, and competencies from Siemens Healthineers.
Latest AACC 2018 News
- Mesa Biotech Showcases PCR Testing Platform at Clinical Expo
- Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018
- Abbott Diagnostics Displays Alinity Family of Systems
- Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC
- Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology
- Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show
- Snibe Diagnostic Presents Immunoassay Systems and Biochemistry Analyzers
- Thermo Fisher Scientific Showcases Product Portfolio at Lab Trade Show
- EKF Diagnostics Highlights Assay Kit and POC Analyzer at AACC 2018
- Randox Laboratories Showcases Advances in Biotechnology at Clinical Lab Expo
- Beckman Coulter Life Sciences Highlights Clinical Flow Cytometry Portfolio
- Beckman Coulter Features New Hematology Analyzers and Lab Automation
- Carolina Liquid Chemistries Promotes Family of Clinical Chemistry Analyzers
- Orion Diagnostica Showcases Rapid Test and Molecular Platform at Lab Show
- Saladax Biomedical Launches Game-Changing Assays at AACC 2018
- SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Portable Blood-Based Device Detects Colon Cancer
Colon cancer is the second leading cause of cancer-related deaths in the U.S., yet it is highly treatable when detected at an early stage. Traditional colonoscopy screenings, although effective, are unpleasant,... Read more
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
New Test Diagnoses High-Risk Childhood Brain Tumors
Medulloblastoma, which originates in the cerebellum, the rear part of the brain, is the most prevalent malignant brain tumor in children and is notoriously difficult to diagnose. Currently, identifying... Read more
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more